精准时代中的肾脏替代治疗管理

doi:10.3969/j.issn.1002-1949.2018.02.002

摘要
图/表
参考文献(27)
相关文章 (15)

全文: PDF (566 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要肾脏替代治疗（RRT）是急性肾损伤（AKI）等重症患者的主要治疗方法，及时合理使用RRT可缓解患者病情。尽管早在上个世纪RRT就已经开始使用，但关于此治疗方法的许多方面仍未达成共识，而且在操作过程中临床实践差异性较大，导致AKI等重症患者病死率仍然很高。2016年第17届ADQI会议提议通过患者选择、治疗时机、溶质控制和液体管理等特定信息对患者实施个体化的“精准RRT”。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	李佳钰
	于凯江

收稿日期: 2017-12-11

通讯作者: 于凯江（1963-），男，教授，主任医师，博士生导师，院长，E-mail:drkaijiang@sohu.com。

作者简介: 李佳钰（1993-），女，硕士研究生。

引用本文:

李佳钰，于凯江. 精准时代中的肾脏替代治疗管理[J]. 中国急救医学, 2018, 38(2): 103-107.
Li Jia-yu, Yu Kai-jiang. RRT management in precision medicinetime. Chinese Journal of Critical Care Medicine, 2018, 38(2): 103-107.

链接本文:

http://www.cnemergency.org.cn/CN/10.3969/j.issn.1002-1949.2018.02.002 或 http://www.cnemergency.org.cn/CN/Y2018/V38/I2/103

［1］Scribner BH, Caner JE, Buri R. The technique of continuous hemodialysis［J］.Trans Am Soc Artif Intern Organs, 1960, 6:88-103. ［2］Kellum JA, Mehta RL, Angus DC, et al. The first international consensus conference on continuous renal replacement therapy［J］. Kidney Int， 2002, 62(5):1855-1863.  ［3］Kellum JA, Ronco C. The 17th Acute Disease Quality Initiative International Consensus Conference: Introducing Precision Renal Replacement Therapy［J］. Blood Purif， 2016， 42(3):221-223. ［4］Cerdá J, Baldwin I, Honore PM, et al.Role of Technology for the Management of AKI in Critically Ill Patients: From Adoptive Technology to Precision Continuous Renal Replacement Therapy［J］. Blood Purif， 2016， 42(3):248-265. ［5］Kumar VA, Craig M, Depner TA, et al. Extended daily dialysis: a new approach to renal replacement for acute renal failure in the intensive care unit［J］. Am J Kidney Dis， 2000， 36(2): 294-300. ［6］Ostermann M, Joannidis M, Pani A, et al. Patient Selection and Timing of Continuous Renal Replacement Therapy［J］. Blood Purif， 2016， 42(3):224-237. ［7］Wu VC, Wang CH, Wang WJ, et al. Sustained low-efficiency dialysis versus continuous veno-venous hemofiltrationfor postsurgical acute renal failure［J］. Am J Surg， 2010， 199(4):466-476.  ［8］Khanal N, Marshall MR, Ma TM, et al. Comparison of outcomes by modality for critically ill patients requiring renal replacement therapy: a single-centre cohort study adjusting for time-varying illness severity and modality exposure［J］. Anaesth Intensive Care， 2012， 40(2):260-268.  ［9］Kumar N, Ahlawat RS. Extended daily dialysis in acute renal failure: a new therapeutic approach［J］. Iran J Kidney Dis， 2007， 1(2):63-72. ［10］Zhang L, Yang J, Eastwood GM, et al. Extended daily dialysis versus continuous renal replacement therapy for acute kidney injury: a meta-analysis［J］. Am J Kidney Dis， 2015， 66(2):322- 330. ［11］Schwenger V, Weigand MA, Hoffmann O, et al. Sustained low efficiency dialysis using a single-pass batch system in acute kidney injury-a randomized interventional trial: the renal replacement therapy study in intensive care unit patients［J］. Crit Care， 2012， 16(4):R140. ［12］Karvellas CJ, Farhat MR, Sajjad I, et al. A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis［J］. Crit Care， 2011， 15(1):R72. ［13］Wierstra BT, Kadri S, Alomar S, et al. The impact of “early” versus “late” initiation of renal replacement therapy in critical care patients with acute kidney injury: a systematic review and evidence synthesis［J］. Crit Care， 2016， 20(1):122. ［14］Pannu N, Klarenbach S, Wiebe N, et al. Renal replacement therapy in patients with acute renal failure: a systematic review［J］. JAMA， 2008， 299(7):793-805.  ［15］Seabra VF, Balk EM, Liangos O, et al. Timing of renal replacement therapy initiation in acute renal failure: a meta-analysis［J］. Am J Kidney Dis， 2008， 52(2):272-284.  ［16］Macedo E, Mehta RL. Continuous dialysis therapies: core curriculum 2016［J］. Am J Kidney Dis, 2016， 68(4)：645-657. ［17］Kidney Disease Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group: KDIGO clinical practice guideline for acute kidney injury［J］. Kidney Int Suppl， 2012， 2:1-138. ［18］Bagshaw SM, Lamontagne F, Joannidis M, et al. When to start renal replacement therapy in critically ill patients with acute kidney injury: comment on AKIKI and ELAIN［J］. Crit Care， 2016， 20（1）:245. ［19］Clark WR, Letteri JJ, Uchino S, et al. Recent clinical advances in the management of critically ill patients with acute renal failure［J］. Blood Purif， 2006， 24（5-6）:487-498.  ［20］Uchino S, Bellomo R, Morimatsu H, et al. Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study［J］. Crit Care Med， 2009， 37(9):2576-2582. ［21］Bagshaw SM, Chakravarthi MR, Ricci Z, et al. Precision Continuous Renal Replacement Therapy and Solute Control［J］. Blood Purif， 2016， 42(3):238-247. ［22］Lewis SJ, Mueller BA. Antibiotic dosing in patients with acute kidney injury: “enough but not too much” ［J］. J Intensive Care Med， 2016， 31(3): 164-176. ［23］Yasuda H, Uchino S, Uji M, et al. The lower limit of intensity to control uremia during continuous renal replacement therapy［J］. Crit Care， 2014， 18(5):539. ［24］Naka T, Bellomo R, Morimatsu H, et al. Acid-base balance in combined severe hepatic and renal failure: a quantitative analysis［J］. Int J Artif Organs， 2008， 31(4):288-294.  ［25］Murugan R, Hoste E, Mehta RL, et al. Precision Fluid Management in Continuous Renal Replacement Therapy［J］. Blood Purif， 2016， 42(3):266-278. ［26］Dangoisse C, Dickie H, Tovey L, et al. Correction of hyper- and hyponatraemia during continuous renal replacement therapy［J］. Nephron Clin Pract， 2014， 128(3-4):394-398.  ［27］Gibney N, Cerda J, Davenport A, et al. Volume management by renal replacement therapy in acute kidney injury［J］. Int J Artif Organs， 2008， 31(2):145-155.